期刊文献+

去甲肾上腺素联合磷酸肌酸钠治疗脓毒症患者的疗效及对氧化应激指标的影响

Efficacy of Norepinephrine Combined with Creatine Phosphate in the Treatment ofPatients with Sepsis and Its Effect on Oxidative Stress Indicators
下载PDF
导出
摘要 目的探究去甲肾上腺素联合磷酸肌酸钠治疗脓毒症患者的疗效及对氧化应激指标的影响。方法回顾性分析2017年2月—2019年6月江门市人民医院收治的78例脓毒症患者的病历资料,根据治疗方式的差异性分为两组,均为39例。对照组行去甲肾上腺素治疗,观察组基于此实施磷酸肌酸钠治疗。比较两组患者氧化应激指标、治疗效果及不良反应。结果治疗后,观察组MDA水平(8.21±1.21)nmol/mg低于对照组,SOD(59.89±6.11)U/mg、GSH-Px水平(78.21±6.25)U/mg高于对照组,差异有统计学意义(t=5.153、7.470、2.132,P<0.05);观察组治疗效果97.44%明显高于对照组79.49%,差异有统计学意义(P<0.05);观察组不良反应率与对照组比较,差异无统计学意义(P>0.05)。结论脓毒症患者予以去甲肾上腺素联合磷酸肌酸钠治疗可抑制氧化应激损伤,提升治疗效果,安全性高。 Objective To explore the efficacy of norepinephrine combined with creatine phosphate in the treatment of patients with sepsis and its effect on oxidative stress indicators.Methods The medical records of 78 patients with sepsis admitted to Jiangmen People's Hospital from Feb⁃ruary 2017 to June 2019 were retrospectively analyzed.According to the differences of treatment methods,they were divided into two groups,with 39 cases in both groups.The control group was treated with norepinephrine,and the observation group was treated with sodium phos⁃phate creatine based on this.The oxidative stress indexes,treatment effects and adverse reactions were compared between the two groups.Re⁃sults After treatment,the level of MDA in the observation group was(8.21±1.21)nmol/mg lower than that in the control group,the levels of SOD(59.89±6.11)U/mg and GSH-Px(78.21±6.25)U/mg were higher than those in the control group,the difference was statistically signifi⁃cant(t=5.153,7.470,2.132,P<0.05);the treatment effect of the observation group was 97.44%significantly higher than that of the control group(79.49%),and the difference was statistically significant(P<0.05);there was no statistically significant difference in the adverse reac⁃tion rate between the observation group and the control group(P>0.05).Conclusion Norepinephrine combined with creatine phosphate in pa⁃tients with sepsis can inhibit oxidative stress injury,improve the therapeutic effect,and has high safety.
作者 邢巧睿 苏焕正 吴霭仪 XING Qiaorui;SU Huanzheng;WU Aiyi(Department of Critical Care Medicine,Jiangmen People's Hospital,Jiangmen,Guangdong Province,529000 China)
出处 《世界复合医学》 2022年第7期184-186,190,共4页 World Journal of Complex Medicine
关键词 去甲肾上腺素 磷酸肌酸钠 脓毒症 氧化应激指标 Norepinephrine Creatine phosphate Sepsis Oxidative stress indicators
  • 相关文献

参考文献16

二级参考文献121

  • 1王瑞兰,许建宁,盛志勇,傅华群.机械通气动态通气参数对急性呼吸窘迫综合征犬肺损伤的影响[J].中国危重病急救医学,2006,18(6):334-337. 被引量:8
  • 2王晓芝,吕长俊,高福全,李笑宏,颜卫峰,宁方玉.目标指导下治疗脓毒性休克的疗效观察[J].中国危重病急救医学,2006,18(11):661-664. 被引量:13
  • 3Karnad DR, Bhadade R,Verma PK, et al. Intravenous ad- ministration of ulinastatin(human urinary trypsin inhibitor) in severe sepsis:a multieenter randomized controlled study []]. Intensive Care Med,2014,40(6):830-838. 被引量:1
  • 4Antonopoulou A,Giamarellos-Bourboulis EJ. Immunomod- ulation in sepsis:state of the art and future perspective [J]. Immunotherapy, 2011,3 ( 1 ) : 117-128. 被引量:1
  • 5Moreira E,Lima R,Navarro LH,et al. Serum Cystatin C is a sensitive early marker for changes in the glomerular fil- tration rate in patients undergoing laparoscopic surgery [J]. Clinics(Sao Paulo),2014,69(6):378-383. 被引量:1
  • 6Karnad DR,Bhadade R,Verma PK,et al. Intravenous administration of ulinastatin (human urinary trypsin in- hibitor)in severe sepsis:a muhicenter randomized con- trolled study [J]. Intensive Care Med,2014,40 (6):830- 838. 被引量:1
  • 7冯丽芝,周青山.乌司他丁治疗脓毒性休克的临床疗效的Meta分析[J].中华临床医师杂志:电子版,2013,7(9):3952-3956. 被引量:1
  • 8Ayub S,Khan S,Ozair U. Cystatin C levels in healthy kid- ney donors and its correlation with GFR by creatinine clearance [J]. J Pak Med Assoc ,2014,64(3) :286-290. 被引量:1
  • 9陈仲清,金英慧,陈辉,付卫军,杨翃,王瑞婷.早期目标指导治疗对多器官功能障碍综合征发病率、严重度及死亡率的影响[J].南方医科大学学报,2007,27(12):1892-1895. 被引量:8
  • 10Fjell CD, Simone T, Hsu JL, et al. Cytokines and signaling mole- cules predict clinical outcomes in sepsis[ J]. PLoS One, 2013, 8 ( 11 ) : e79207-e79207. 被引量:1

共引文献939

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部